Discover 3,059 paid clinical trials in Cambridge, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
Noninvasive Continuous BP Monitoring in Newborns Based on Pulsatile Signal Morphological Features Using NIRS
for
Unstable Blood Pressure, Hypotension
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 0
Code: NCT06994494
Recruiting
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Location: Boston MA, Providence RI, Decatur GA, Omaha NE,
Sponsor: VA Office of Research and Development
Sex: All
Age: 35 - 70+
Code: NCT05937854
Phase 2, Recruiting
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Boston MA, Hackensack NJ, New York NY, Baltimore MD,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05372354
Phase 1, Phase 2, Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Boston MA, Providence RI, Stony Brook NY, Roslyn NY,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase 3, Recruiting
Phase III Presbyopia Correction Using the VIS Opti-K™ System
for
Presbyopia
Location: South Dartmouth MA, Oceanside NY, Teaneck NJ,
Sponsor: VIS, Inc.
Sex: All
Age: 40+
Code: NCT06487897
Phase 3, Recruiting
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
for
Cholangiocarcinoma, Pancreatic Cancer, Bile Duct Cancer,
Location: Boston MA, New York NY
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT01439698
Recruiting
Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
for
Immunoglobulin Light Chain (AL) Amyloidosis
Location: Boston MA, New York NY, Winston-Salem NC, Charlotte NC,